Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/22/2021 01/25/2021 01/26/2021 01/27/2021 01/28/2021 Date
329.8(c) 335.8(c) 334(c) 342(c) 334.2 Last
59 375 70 506 65 169 125 284 43 637 Volume
+2.30% +1.82% -0.54% +2.40% -2.28% Change
More quotes
Financials
Sales 2020 1 877 M 2 270 M 2 270 M
Net income 2020 342 M 413 M 413 M
Net Debt 2020 261 M 316 M 316 M
P/E ratio 2020 91,9x
Yield 2020 0,27%
Sales 2021 2 283 M 2 760 M 2 760 M
Net income 2021 421 M 509 M 509 M
Net Debt 2021 164 M 199 M 199 M
P/E ratio 2021 74,3x
Yield 2021 0,34%
Capitalization 31 526 M 38 134 M 38 118 M
EV / Sales 2020 16,9x
EV / Sales 2021 13,9x
Nbr of Employees 6 979
Free-Float 25,7%
More Financials
Company
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and... 
More about the company
Notations Surperformance© of Sartorius Stedim Biotech
Trading Rating : Investor Rating :
More Ratings
All news about SARTORIUS STEDIM BIOTECH
01/27SARTORIUS STEDIM BIOTECH : with exceptionally strong growth in 2020...
PU
01/27SARTORIUS STEDIM BIOTECH : with exceptionally strong growth in 2020 and a furthe..
PR
01/27SARTORIUS STEDIM BIOTECH : closes 2020 with strong growth to well over 2 billion..
PU
01/15SARTORIUS STEDIM BIOTECH : Partners With RoosterBio to Advance Cell and Gene...
PU
01/06SARTORIUS STEDIM BIOTECH : to acquire Novasep's chromatography...
PU
01/05SARTORIUS STEDIM BIOTECH : Annual Report 2020 of the Liquidity Contract with the..
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 du contrat de liquidité contra..
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of the liquidity contract with th..
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de dro..
DJ
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and v..
DJ
2020SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and vo..
CO
More news
News in other languages on SARTORIUS STEDIM BIOTECH
01/27CORR OFFICIELLE : Sartorius Stedim compte poursuivre sa croissance en 2021
01/27SARTORIUS STEDIM BIOTECH : grimpe en Bourse après un exercice 2020 solide
01/27L'Europe en baisse avant la Fed, sauf le CAC, grâce à LVMH et Unibail
01/27FMI, Super-cycle et Microsoft au programme
01/27EN DIRECT DES MARCHES : LVMH, Microsoft, Sartorius, Somfy, Solutions 30, Sanofi,..
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 2020
The underlying trend is to the upside
BUY
More Stock Trading Analysis
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | MarketScreener
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 289,63 €
Last Close Price 342,00 €
Spread / Highest target 13,5%
Spread / Average Target -15,3%
Spread / Lowest Target -43,6%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chairman & Chief Executive Officer
Volker Niebel Executive VP-Operations & Information Technology
Oscar-Werner Reif Executive VP-Research & Development
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS STEDIM BIOTECH17.45%38 134
ABBOTT LABORATORIES4.38%195 825
MEDTRONIC PLC-4.81%150 081
BECTON, DICKINSON AND COMPANY0.27%72 972
HOYA CORPORATION-3.92%47 286
ALIGN TECHNOLOGY, INC.-4.63%40 185